Literature DB >> 22570287

Ten years of progress in colon cancer therapy.

Paul F Engstrom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22570287     DOI： 10.6004/jnccn.2012.0058

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  2 in total

1.  Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome.

Authors:  Fangfang Tao; Ping Lü; Chunbo Xu; Mengmeng Zheng; Wenhong Liu; Minhe Shen; Shanming Ruan
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-24       Impact factor: 2.629

2.  Verticillin A inhibits colon cancer cell migration and invasion by targeting c-Met.

Authors:  Qian-Qian Liu; Xue-Li Zeng; Yue-Lin Guan; Jing-Xin Lu; Kai Tu; Fei-Yan Liu
Journal:  J Zhejiang Univ Sci B       Date:  2020-10       Impact factor: 3.066
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.